— Know what they know.
Not Investment Advice

THCT OTC

THC Therapeutics, Inc.
1W: -50.0% 1M: -50.0% 3M: -66.7% YTD: +200.0% 1Y: -40.0% 3Y: +1300.0% 5Y: -80.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · $11660 mcap · 30M float · 0.0014% daily turnover · Short 62% of daily vol

Balance Sheet Trends

Total Assets
$13K -93.7% ▼
5Y CAGR: -65.1%
Total Liabilities
$3M +0.2% ▲
5Y CAGR: +41.7%
Shareholders Equity
-$3M -6.4% ▼
Cash & Investments
$10 -68.8% ▼
5Y CAGR: -68.0%
Total Debt
$791K -1.2% ▼
5Y CAGR: +35.0%
Net Debt
$791K -1.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$318K$43K$296K$32$10
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$318K$43K$296K$32$10
Net Receivables$0$0$0$0$0
Inventory$0$0$830$25$0
Other Current Assets$0$0$0$0$0
Total Current Assets$458K$43K$302K$41K$980
Property, Plant & Equip.$37K$21K$9K$0$0
Goodwill & Intangibles$25K$21K$16K$13K$12K
Long-Term Investments$0$0$153K$153K$0
Other Non-Current Assets-$0$0$153K$0$0
Total Non-Current Assets$62K$42K$179K$166K$12K
Total Assets$520K$85K$480K$207K$13K
— Liabilities —
Accounts Payable$159K$571K$970K$2M$2M
Short-Term Debt$178K$430K$858K$801K$791K
Deferred Revenue$322K$92K$610K$0$0
Other Current Liabilities$715K$762K$391K$818K$490K
Total Current Liabilities$1M$2M$3M$3M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$100K$100K$100K
Total Non-Current Liabilities$0$929K$100K$100K$100K
Total Liabilities$1M$2M$3M$3M$3M
— Equity —
Common Stock$14K$21K$29K$32K$33K
Retained Earnings-$33M-$35M-$37M-$38M-$38M
Accumulated OCI-$6M-$7M-$6M-$6M-$6M
Total Stockholders Equity-$749K-$2M-$2M-$3M-$3M
Total Liabilities & Equity$520K$85K$480K$207K$13K
— Key Metrics —
Total Debt$178K$430K$761K$801K$791K
Net Debt-$140K$387K$465K$801K$791K
Total Investments$0$0$153K$153K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms